Caveolin-1-deficient mice show accelerated mammary gland development during pregnancy, premature lactation, and hyperactivation of the Jak-2/STAT5a signaling cascade

Molecular Biology of the Cell

Volumn 13, Issue 10, 2002, Pages 3416-3430

  Park, David S ^a   Lee, Hyangkyu ^a   Frank, Philippe G ^a   Razani, Babak ^a   Nguyen, Andrew V ^a   Parlow, Albert F ^a   Russell, Robert G ^a   Hulit, James ^a   Pestell, Richard G ^a   Lisanti, Michael P ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN 1; CYTOKINE; JAK 2 TYROSINE KINASE; JANUS KINASE; LUCIFERASE; PROLACTIN; STAT5 PROTEIN; STAT5A PROTEIN; UNCLASSIFIED DRUG; CARRIER PROTEIN; CAV1 PROTEIN, MOUSE; CAVEOLIN; DNA BINDING PROTEIN; ESTROGEN; JAK2 PROTEIN, MOUSE; JANUS KINASE 2; MILK PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; ONCOPROTEIN; PROGESTERONE; PROTEIN; PROTEIN TYROSINE KINASE; REPRESSOR PROTEIN; SOCS1 PROTEIN, MOUSE; SOCS3 PROTEIN, MOUSE; STAT5A PROTEIN, MOUSE; SUPPRESSOR OF CYTOKINE SIGNALING; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; BREAST EPITHELIUM; CONTROLLED STUDY; DNA BINDING; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME REGULATION; FEMALE; GENE ACTIVATION; HORMONAL REGULATION; HORMONE RECEPTOR INTERACTION; IN VIVO STUDY; LACTATION; MAMMARY GLAND; MOLECULAR MECHANICS; MOUSE; NONHUMAN; ORGANOGENESIS; PHENOTYPE; PREGNANCY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REPORTER GENE; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; AMINO ACID SEQUENCE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL LINE; CELL MEMBRANE; CYTOLOGY; DOWN REGULATION; EPITHELIUM CELL; GENETICS; GROWTH, DEVELOPMENT AND AGING; LACTATION DISORDER; METABOLISM; MOLECULAR GENETICS; MOUSE MUTANT; PHYSIOLOGY; SEQUENCE ALIGNMENT; UDDER;

AMINO ACID SEQUENCE; ANIMALS; CARRIER PROTEINS; CAVEOLIN 1; CAVEOLINS; CELL LINE; CELL MEMBRANE; DNA-BINDING PROTEINS; DOWN-REGULATION; ENZYME ACTIVATION; EPITHELIAL CELLS; ESTROGENS; FEMALE; GENES, REPORTER; JANUS KINASE 2; LACTATION DISORDERS; MAMMARY GLANDS, ANIMAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MILK PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASES; MOLECULAR SEQUENCE DATA; PREGNANCY; PROGESTERONE; PROLACTIN; PROTEIN-TYROSINE KINASES; PROTEINS; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 0036798278     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.02-05-0071     Document Type: Article

References (50)

1. Ali, S. (1998). Prolactin receptor regulates Stat5 tyrosine phosphorylation and nuclear translocation by two separate pathways. J. Biol. Chem. 273, 7709-16.
2. Clontech, Inc. (2000a). Infinity Human Mammary Epithelial Cell Line. CLONTECHniques XV, 1-2.
3. Clontech, Inc. (2000b). Infinity Telomerase-Immortalized Cell Lines. CLONTECHniques XIV, 2-3.
4. Couet, J., Li., S., Okamoto, T., Ikezu, T., and Lisanti, M.P. (1997). Identification of peptide and protein ligands for the caveolin-scaffolding domain: implications for the interaction of caveolin with caveolae-associated proteins. J. Biol. Chem. 272, 6525-6533.
5. Engelman, J.A., Chu, C., Lin, A., Jo, H., Ikezu, T., Okamoto, T., Kohtz, D.S., and Lisanti, M.P. (1998a). Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo: a role for the caveolin-scaffolding domain. FEBS Lett. 428, 205-211.
6. Engelman, J.A., Lee, R.J., Karnezis, A., Bearss, D.J., Webster, M., Siegel, P., Muller, W.J., Windle, J.J., Pestell, R.G., and Lisanti, M.P. (1998b). Reciprocal regulation of Neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo: implications for human breast cancer. J. Biol. Chem. 273, 20448-20455.
7. Engelman, J.A., Wycoff, C.C., Yasuhara, S., Song, K.S., Okamoto, T., and Lisanti, M.P. (1997). Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth. J. Biol. Chem. 272, 16374-16381.
8. Engelman, J.A., Zhang, X.L., Pestell, R.G., and Lisanti, M.P. (1999). p42/44 MAP kinase-dependent and -independent signaling pathways regulate caveolin-1 gene expression. J. Biol. Chem. 274, 32333-32341.
9. Fiucci, G., Ravid, D., Reich, R., and Liscovitch, M. (2002). Caveolin-1 inhibits anchorage-independent growth, anoikis and invasiveness in MCF-7 human breast cancer cells. Oncogene 21, 2365-2375.
10. Fra, A.M., Masserini, M., Palestini, P., Sonnino, S., and Simons, K. (1995). A photo-reactive derivative of ganglioside GM1 specifically cross-links VIP21-caveolin on the cell surface. FEBS Lett. 375, 11-14.
11. Freeman, M.E., Kanyicska, B., Lerant, A., and Nagy, G. (2000). Prolactin: structure, function, and regulation of secretion. Physiol Rev. 80, 1523-1631.
12. Galbiati, F., Razani, B., and Lisanti, M.P. (2001). Emerging themes in lipid rafts and caveolae. Cell 106, 403-411.
13. Galbiati, F., Volonté, D., Engelman, J.A., Watanabe, G., Burk, R., Pestell, R., and Lisanti, M.P. (1998). Targeted down-regulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade. EMBO J. 17, 6633-6648.
14. Garcia-Cardena, G., Oh, P., Liu, J., Schnitzer, J.E., and Sessa, W.C. (1996). Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for caveolae localization. Proc. Natl. Acad. Sci. USA 93, 6448-6453.
15. Goffin, V., Binart, N., Clement-Lacroix, P., Bouchard, B., Bole-Feysot, C., Edery, M., Lucas, B.K., Touraine, P., Pezet, A., Maaskant, R., Pichard, C., Helloco, C., Baran, N., Favre, H., Bernichtein, S., Allamando, A., Ormandy, C., and Kelly, P.A. (1999). From the molecular biology of prolactin and its receptor to the lessons learned from knockout mice models. Genet. Anal. 15, 189-201.
16. Hennighausen, L., and Robinson, G.W. (1998). Think globally, act locally: the making of a mouse mammary gland. Genes Dev. 12, 449-455.
17. Krebs, D.L., and Hilton, D.J. (2000). SOCS: physiological suppressors of cytokine signaling. J. Cell Sci. 113, 2813-2819.
18. Li, S., Couet, J., and Lisanti, M.P. (1996a). Src tyrosine kinases, G alpha subunits and H-Ras share a common membrane-anchored scaffolding protein, caveolin: caveolin binding negatively regulates the auto-activation of Src tyrosine kinases. J. Biol. Chem. 271, 29182-29190.
19. Li, S., Seitz, R., and Lisanti, M.P. (1996b). Phosphorylation of caveolin by Src tyrosine kinases: The a-isoform of caveolin is selectively phosphorylated by v-Src in vivo. J. Biol. Chem. 271, 3863-3868.
20. Li, S., Song, K.S., and Lisanti, M.P. (1996c). Expression and characterization of recombinant caveolin: purification by poly-histidine tagging and cholesterol-dependent incorporation into defined lipid membranes. J. Biol. Chem. 271, 568-573.
21. Lindeman, G.J., Wittlin, S., Lada, H., Naylor, M.J., Santamaria, M., Zhang, J.G., Starr, R., Hilton, D.J., Alexander, W.S., Ormandy, C.J., and Visvader, J. (2001). SOCS1 deficiency results in accelerated mammary gland development and rescues lactation in prolactin receptor-deficient mice. Genes Dev. 15, 1631-1636.
22. Lisanti, M.P., Scherer, P.E., Vidugiriene, J., Tang, Z.-L., Hermanoski-Vosatka, A., Tu, Y.-H., Cook, R.F., and Sargiacomo, M. (1994). Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease. J. Cell Biol. 126, 111-126.
23. Lisanti, M.P., Tang, Z.-T., Scherer, P., and Sargiacomo, M. (1995). Caveolae purification and GPI-linked protein sorting in polarized epithelia. Methods Enzymol. 250, 655-668.
24. Liu, X., Robinson, G.W., Wagner, K.U., Garrett, L., Wynshaw-Boris, A., and Hennighausen, L. (1997). Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev. 11, 179-186.
25. Matsumura, I., Kitamura, T., Wakao, H., Tanaka, H., Hashimoto, K., Albanese, C., Downward, J., Pestell, R.G., and Kanakura, Y. (1999). Transcriptional regulation of the cyclin D1 promoter by STAT5: its involvement in cytokine-dependent growth of hematopoietic cells. EMBO J. 18, 1367-1377.
26. Mills, L.H., Lee, A.J., Parlow, A.F., and Zhu, B.T. (2001). Preferential growth stimulation of mammary glands over uterine endometrium in female rats by a naturally occurring estradiol-17beta-fatty acid ester. Cancer Res. 61, 5764-5770.
27. Murata, M., Peranen, J., Schreiner, R., Weiland, F., Kurzchalia, T., and Simons, K. (1995). VIP21/caveolin is a cholesterol-binding protein. Proc. Natl. Acad. Sci. USA 92, 10339-10343.
28. Naka, T., Fujimoto, M., and Kishimoto, T. (1999). Negative regulation of cytokine signaling: STAT-induced STAT inhibitor. Trends Biochem. Sci. 24, 394-398.
29. Okamoto, T., Schlegel, A., Scherer, P.E., and Lisanti, M.P. (1998). Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J. Biol. Chem. 273, 5419-5422.
30. Park, D.S., Lee, H., Riedel, C., Hulit, J., Scherer, P.E., Pestell, R.G., and Lisanti, M.P. (2001). Prolactin negatively regulates caveolin-1 gene expression in the mammary gland during lactation, via a Ras-dependent mechanism. J. Biol. Chem. 276, 48389-48397.
31. Parolini, I., Sargiacomo, M., Galbiati, F., Rizzo, G., Grignani, F., Engelman, J.A., Okamoto, T., Ikezu, T., Scherer, P.E., Mora, R., Rodriguez-Boulan, E., Peschle, C., and Lisanti, M.P. (1999). Expression of caveolin-1 is required for the transport of caveolin-2 to the plasma membrane. Retention of caveolin-2 at the level of the Golgi complex. J. Biol. Chem. 274, 25718-25725.
32. Parton, R.G. (1996). Caveolae and caveolins. Curr. Opin. Cell Biol. 8, 542-548.
33. Pestell, R.G., Albanese, C., Hollenberg, A., and Jameson, J.L. (1994). c-Jun represses transcription of the human chorionic gonadotropin alpha and beta genes through distinct types of CREs. J. Biol. Chem. 269, 31090-31096.
34. Razani, B., Engelman, J.A., Wang, X.B., Schubert, W., Zhang, X.L., Marks, C.B., Macaluso, F., Russell, R.G., Li, M., Pestell, R.G., Di Vizio, D., Hou, H., Jr., Kneitz, B., Lagaud, G., Christ, G.J., Edelmann, W., and Lisanti, M.P. (2001). Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J. Biol. Chem. 276, 38121-38138.
35. Razani, B., Schlegel, A., and Lisanti, M.P. (2000). Caveolin proteins in signaling, oncogenic transformation and muscular dystrophy. J. Cell Sci. 113, 2103-2109.
36. Razani, B., Wang, X.B., Engelman, J.A., Battista, M., Lagaud, G., Zhang, X.L., Kneitz, B., Hou, H., Christ, G.H., Edelmann, W., and Lisanti, M.P. (2002). Caveolin-2 deficient mice show evidence of severe pulmonary dysfunction, without disruption of caveolae formation. Molec. Cell. Biol. 22, 2329-2344.
37. Rothberg, K.G., Heuser, J.E., Donzell, W.C., Ying, Y., Glenney, J.R., and Anderson, R.G.W. (1992). Caveolin, a protein component of caveolae membrane coats. Cell 68, 673-682.
38. Sargiacomo, M., Scherer, P.E., Tang, Z.-L., Kubler, E., Song, K.S., Sanders, M.C., and Lisanti, M.P. (1995). Oligomeric structure of caveolin: implications for caveolae membrane organization. Proc. Natl. Acad. Sci. USA 92, 9407-9411.
39. Scheel, J., Srinivasan, J., Honnert, U., Henske, A., and Kurzchalia, T.V. (1999). Involvement of caveolin-1 in meiotic cell-cycle progression in Caenorhabditis elegans. Nat. Cell Biol. 1, 127-129.
40. Scherer, P.E., Lewis, R.Y., Volonte, D., Engelman, J.A., Galbiati, F., Couet, J., Kohtz, D.S., van Donselaar, E., Peters, P., and Lisanti, M.P. (1997). Cell-type and tissue-specific expression of caveolin-2: caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo. J. Biol. Chem. 272, 29337-29346.
41. Scherer, P.E., Okamoto, T., Chun, M., Nishimoto, I., Lodish, H.F., and Lisanti, M.P. (1996). Identification, sequence and expression of caveolin-2 defines a caveolin gene family. Proc. Natl. Acad. Sci. USA 93, 131-135.
42. Scherer, P.E., Tang, Z.-L., Chun, M.C., Sargiacomo, M., Lodish, H.F., and Lisanti, M.P. (1995). Caveolin isoforms differ in their N-terminal protein sequence and subcellular distribution: identification and epitope mapping of an isoform-specific monoclonal antibody probe. J. Biol. Chem. 270, 16395-16401.
43. Shaul, P.W., Smart, E.J., Robinson, L.J., German, Z., Yuhanna, I.S., Ying, Y., Anderson, R.G.W., and Michel, T. (1996). Acylation targets endothelial nitric-oxide synthase to plasmalemmal caveolae. J. Biol. Chem. 271, 6518-6522.
44. Smart, E.J., Graf, G.A., McNiven, M.A., Sessa, W.C., Engelman, J.A., Scherer, P.E., Okamoto, T., and Lisanti, M.P. (1999). Caveolins, liquid-ordered domains, and signal transduction. Mol. Cell Biol. 19, 7289-7304.
45. Song, K.S., Li, S., Okamoto, T., Quilliam, L., Sargiacomo, M., and Lisanti, M.P. (1996). Copurification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains: detergent free purification of caveolae membranes. J. Biol. Chem. 271, 9690-9697.
46. Subramaniam, A., Gulick, J., and Robbins, J. (1990). Analysis of the upstream regulatory region of a chicken skeletal myosin heavy chain gene. J. Biol. Chem. 265, 13986-13994.
47. Tang, Z.-L., Scherer, P.E., Okamoto, T., Song, K., Chu, C., Kohtz, D.S., Nishimoto, I., Lodish, H.F., and Lisanti, M.P. (1996). Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J. Biol. Chem. 271, 2255-2261.
48. Wartmann, M., Cella, N., Hofer, P., Groner, B., Liu, X., Hennighausen, L., and Hynes, N.E. (1996). Lactogenic hormone activation of Stat5 and transcription of the beta-casein gene in mammary epithelial cells is independent of p42 ERK2 mitogen-activated protein kinase activity. J. Biol. Chem. 271, 31863-31868.
49. Yasukawa, H., Misawa, H., Sakamoto, H., Masuhara, M., Sasaki, A., Wakioka, T., Ohtsuka, S., Imaizumi, T., Matsuda, T., Ihle, J.N., and Yoshimura, A. (1999). The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop. EMBO J. 18, 1309-1320.
50. Zhang, W., Razani, B., Altschuler, Y., Bouzahzah, B., Mostov, K.E., Pestell, R.G., and Lisanti, M.P. (2000). Caveolin-1 inhibits epidermal growth factor-stimulated lamellipod extension and cell migration in metastatic mammary adenocarcinoma cells (MTLn3): transformation suppressor effects of adenovirus-mediated gene delivery of caveolin-1. J. Biol. Chem. 275, 20717-20725.